Hermetica Superfood Encyclopedia
The Short Answer
Chanca Piedra contains the marker lignans phyllanthin and hypophyllanthin, alongside ellagitannins and flavonoids, which collectively exert antioxidant, antispasmodic, and urinary-alkalinizing effects that may facilitate the passage or dissolution of calcium oxalate kidney stones. Preclinical and limited clinical evidence suggests it reduces urinary calcium and oxalate excretion, inhibits calcium oxalate crystal aggregation in vitro, and provides hepatoprotective activity against chemically induced liver injury in animal models.
CategoryHerb
GroupAmazonian
Evidence LevelPreliminary
Primary Keywordchanca piedra benefits
Chanca Piedra — botanical close-up
Health Benefits
**Kidney Stone Reduction**
Phyllanthin, hypophyllanthin, and ellagic acid appear to inhibit calcium oxalate crystal nucleation and aggregation in vitro, while traditional and preliminary clinical use in Brazil supports reduced stone passage time and decreased urinary calcium excretion.
**Hepatoprotection**
Aqueous and ethanolic extracts protect hepatocytes against carbon tetrachloride-induced cytotoxicity in rat models, attributed to free radical scavenging by phenolics such as geraniin, corilagin, and chlorogenic acid that attenuate oxidative damage to liver parenchyma.
**Antioxidant Activity**: The 50% methanolic extract achieves a DPPH IC50 of 2
72 μg/mL and total phenolic content of 324 μg GAE/mg, reflecting potent free radical scavenging driven by flavonoids rutin, quercetin, catechin, and epicatechin.
**Antidiabetic Potential**
Standardized extracts inhibit α-glucosidase and pancreatic lipase in vitro, with the lowest IC50 values observed in freeze-dried 80% ethanol preparations, suggesting capacity to attenuate postprandial glucose and lipid absorption.
**Antiviral Activity Against Hepatitis B**
Phyllanthin and related lignans have demonstrated inhibition of hepatitis B surface antigen (HBsAg) secretion and viral DNA polymerase activity in cell culture, positioning the herb as a candidate adjunct in hepatitis B management.
**Antibacterial Properties**
Ethanolic extracts exhibit inhibitory activity against gram-negative Escherichia coli and gram-positive Staphylococcus aureus, likely through disruption of bacterial membrane integrity and enzymatic pathways by phenolic and terpenoid constituents.
**Anti-obesity and Lipase Inhibition**
Pancreatic lipase inhibition by 80% ethanolic extract fractions suggests a mechanism for reducing dietary fat absorption, paralleling the pharmacology of orlistat at a molecular level, though human efficacy data are lacking.
Origin & History
Natural habitat
Phyllanthus niruri is a small annual herbaceous plant native to tropical and subtropical regions of the Amazon basin in South America, as well as Central America, the Caribbean, and parts of Asia and Africa. It thrives in moist, disturbed soils along roadsides, coastal areas, and forest margins at low elevations, typically below 1,000 meters. The plant is widely distributed across Brazil, where it is called 'quebra pedra' (stone breaker), and throughout Malaysia, India, and the Philippines, growing as a weed in humid climates with abundant rainfall.
“Phyllanthus niruri has been employed in traditional medicine for at least several centuries across South America, Southeast Asia, and the Indian subcontinent, with its most celebrated use being the dissolution and expulsion of kidney stones and gallstones—reflected in its Brazilian Portuguese name 'quebra pedra' (stone breaker) and its Peruvian Spanish name 'chancapiedra.' In Ayurvedic medicine, related Phyllanthus species are documented in classical texts as 'Bhumyamalaki,' used to treat jaundice, hepatitis, and urinary disorders through liver-cooling and diuretic actions. Malaysian traditional healers refer to the plant as 'dukung anak' and use whole-plant decoctions for childhood fever, dysentery, and urinary infections, while West Indian folk practitioners prepare leaf infusions for diabetes and hypertension management. The herb was formally brought to Western scientific attention in the 1980s when a landmark paper in The Lancet (1988) by Thyagarajan et al. reported its potential hepatitis B antiviral activity, catalyzing decades of phytochemical investigation despite subsequent inconsistency in clinical replication.”Traditional Medicine
Scientific Research
The evidence base for Chanca Piedra consists predominantly of in vitro assays and small animal model studies, with very limited rigorous human clinical trial data; no large randomized controlled trials (RCTs) with reported effect sizes were identified in the current literature review. Preclinical studies have demonstrated calcium oxalate crystal inhibition in cell-free systems, hepatoprotection in carbon tetrachloride-challenged rat models consistent with reduced serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST), and α-glucosidase inhibition with IC50 values dependent on extraction solvent and drying method. A small number of open-label or pilot human studies conducted primarily in Brazil have suggested reductions in urinary calcium excretion and facilitated stone expulsion, but these lack adequate blinding, control groups, and statistical power to permit definitive conclusions. Overall, the evidence tier is preliminary-to-moderate; the herb's long traditional use provides biological plausibility, but robust Phase II/III RCTs are required to confirm therapeutic efficacy and optimal dosing in humans.
Preparation & Dosage
Traditional preparation
**Dried Whole Herb (Tea/Decoction)**
500 mL water for 10–15 minutes, consumed 2–3 times daily; traditional Amazonian preparation most commonly cited for kidney stone support
3–5 grams of dried aerial parts boiled in .
**Standardized Capsules/Tablets**
000 mg per dose, 2–3 times daily; ideally standardized to a minimum of 1–2% phyllanthin by HPLC to ensure consistent lignan content
500–1,.
**Hydroethanolic Liquid Extract (1
2–4 mL up to three times daily in water; 50–80% ethanol extractions preserve the highest phenolic and lignan concentrations relative to aqueous preparations
1 or 1:2)**: .
**Freeze-Dried Powder**
400–600 mg per serving are commercially available
Preferred laboratory-grade form shown to yield the highest hypophyllanthin content and DPPH antioxidant activity; encapsulated products at .
**Timing**
Best taken between meals to maximize urinary alkalinization and minimize gastrointestinal dilution effects; consistent daily use over 4–12 weeks appears necessary in traditional protocols.
**Standardization Note**
No internationally recognized pharmacopeial standard exists; consumers should seek products that specify phyllanthin and/or hypophyllanthin content and third-party testing for heavy metals given the plant's soil accumulation potential.
Nutritional Profile
Phyllanthus niruri aerial parts contain modest levels of primary macronutrients inherent to leafy herbaceous material, with protein content approximately 15–20% of dry weight and carbohydrates comprising 40–50% of dry weight including dietary fiber. Micronutrients include potassium, calcium, phosphorus, and trace iron, though concentrations vary by soil composition and are not clinically significant at supplemental doses. The primary phytochemical signature includes lignans (phyllanthin, hypophyllanthin, niranthin, nirtetralin), ellagitannins (geraniin, corilagin, furosin), flavonoids (rutin, quercetin, kaempferol glycosides, catechin, epicatechin), phenolic acids (gallic, ellagic, chlorogenic, caffeic), alkaloids (norsecurinine, phyllanthidine), saponins, steroids (beta-sitosterol), and terpenoids. In optimized 50% methanolic extracts, total phenolic content reaches approximately 324 μg GAE/mg dry extract and total flavonoid content approximately 64 μg QE/mg dry extract; bioavailability of lignans and phenolics is significantly enhanced by hydroethanolic versus aqueous extraction, and freeze-drying of raw material prior to extraction further preserves thermolabile constituents such as catechins and hypophyllanthin.
How It Works
Mechanism of Action
The lignans phyllanthin and hypophyllanthin act as the principal marker compounds of Phyllanthus niruri, and together with ellagitannins such as geraniin and corilagin, they donate hydrogen atoms or electrons to neutralize reactive oxygen species (ROS) via DPPH, ABTS, and FRAP pathways, reducing oxidative stress in hepatic and renal tissues. Flavonoids including quercetin and rutin modulate nuclear factor-erythroid 2-related factor 2 (Nrf2) signaling and inhibit pro-inflammatory cyclooxygenase (COX) and lipoxygenase (LOX) enzymes, thereby attenuating inflammatory cascades implicated in stone formation and liver fibrosis. Alkalinization of urine and chelation of calcium ions by phenolic acids such as ellagic and chlorogenic acid reduce the supersaturation of calcium oxalate and inhibit crystal nucleation through direct interference with crystal surface binding sites. α-Glucosidase inhibition by flavonoid and lignan fractions competitively blocks the hydrolysis of dietary carbohydrates at the intestinal brush border, delaying glucose absorption and blunting postprandial glycemic excursions.
Clinical Evidence
Available clinical data consist of small, uncontrolled or poorly controlled pilot studies rather than phase III RCTs; the most frequently studied outcome is kidney stone passage and urinary lithogenic risk factor reduction in patients with urolithiasis. One referenced open-label Brazilian study reported decreased urinary calcium and uric acid levels over a 3-month course of whole-plant tea, but sample sizes were fewer than 100 participants and blinding was absent. Hepatitis B pilot trials using Phyllanthus species extracts showed transient reductions in HBsAg titers in some participants, though results were inconsistent across trials and confounded by species misidentification between P. niruri, P. amarus, and P. urinaria. Confidence in current clinical findings is low-to-moderate; effect sizes reported are not reliably reproducible, and standardization of extract composition across studies remains a critical unresolved issue.
Safety & Interactions
Chanca Piedra is generally considered well-tolerated at traditional tea doses and in short-term supplementation trials, with no severe adverse events systematically documented; mild gastrointestinal symptoms such as nausea or diarrhea have been anecdotally reported at high doses. Clinically relevant drug interactions are theoretically plausible: the herb's demonstrated α-glucosidase inhibition and glucose-lowering activity in animal models warrant caution when combined with oral antidiabetic agents such as metformin or sulfonylureas due to additive hypoglycemic risk, and its diuretic and urinary alkalinizing properties may alter renal clearance of lithium or methotrexate. Anticoagulant and antiplatelet interactions are a theoretical concern given the quercetin and rutin content, which can inhibit platelet aggregation in vitro, suggesting caution in patients on warfarin or clopidogrel without medical supervision. Pregnancy and lactation safety has not been established in controlled studies; the herb has historically been noted to have potential uterotonic and abortifacient properties in animal experiments, and use during pregnancy is contraindicated until human safety data are available.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Phyllanthus niruriQuebra PedraStone BreakerDukung AnakChancapiedraBhumyamalakiSeed-Under-Leaf
Frequently Asked Questions
How does chanca piedra help with kidney stones?
Chanca Piedra contains ellagic acid, phenolic acids, and the lignans phyllanthin and hypophyllanthin, which in vitro studies show can inhibit calcium oxalate crystal nucleation and aggregation—the primary mechanism of kidney stone formation. Additionally, compounds in the plant promote urine alkalinization and may reduce urinary calcium and uric acid excretion, making the urinary environment less favorable for stone growth. Small clinical observations from Brazil support facilitated stone expulsion, though large randomized controlled trials are still needed to confirm these effects definitively.
What is the recommended dosage of chanca piedra?
No universally standardized dose has been established through large clinical trials, but traditional Amazonian practice involves drinking a decoction of 3–5 grams of dried aerial parts in 500 mL of water two to three times daily. Commercial capsules are typically dosed at 500–1,000 mg per serving two to three times daily, ideally from products standardized to 1–2% phyllanthin content by HPLC to ensure consistency. Most traditional protocols are followed for 4–12 weeks continuously; users should consult a healthcare provider before beginning supplementation, especially if taking medications for diabetes or anticoagulation.
Is chanca piedra safe to take daily?
Short-term traditional use and preliminary safety data suggest chanca piedra is generally well tolerated at typical doses, with no serious adverse events systematically documented in the available literature. However, due to its blood glucose-lowering and diuretic properties, individuals on antidiabetic drugs, diuretics, lithium, or anticoagulants should exercise caution and seek medical advice before daily use. Long-term safety data from controlled human studies are absent, and the herb is contraindicated in pregnancy based on animal evidence of uterotonic activity.
Does chanca piedra work for liver disease or hepatitis B?
Phyllanthin and related lignans in Chanca Piedra have demonstrated inhibition of hepatitis B surface antigen (HBsAg) secretion and viral DNA polymerase in cell culture studies, generating significant scientific interest since the original 1988 Lancet report by Thyagarajan et al. Animal model studies also show hepatoprotective effects against chemically induced liver injury, with reductions in serum liver enzyme markers (ALT, AST). However, subsequent clinical trials in hepatitis B patients have produced inconsistent results, and the herb is not an established standard-of-care treatment; it may have value as a supportive adjunct but should not replace antiviral therapy.
What part of the chanca piedra plant is used medicinally?
The entire aerial portion of Phyllanthus niruri—including leaves, stems, and small roots—is used medicinally, and most traditional preparations employ the whole plant rather than isolated parts. Leaves are the richest source of flavonoids such as rutin and quercetin, while stems and roots contribute higher concentrations of lignans including phyllanthin and hypophyllanthin. Scientific extraction studies confirm that freeze-dried whole aerial parts extracted in 80% ethanol yield the highest concentrations of hypophyllanthin, total phenolics, and antioxidant activity compared to water or lower-ethanol preparations.
Does chanca piedra interact with blood pressure or diabetes medications?
Chanca piedra may have mild antihypertensive and glucose-lowering properties, which could theoretically potentiate the effects of blood pressure and diabetes medications. If you are taking medications for hypertension or diabetes, consult your healthcare provider before using chanca piedra supplements, as dose adjustments may be necessary. Clinical interaction data is limited, so professional medical guidance is important for safe concurrent use.
Is chanca piedra safe during pregnancy and breastfeeding?
There is insufficient clinical evidence to establish the safety of chanca piedra during pregnancy and breastfeeding, so it is not recommended without medical supervision. Traditional use in some cultures does not guarantee safety for pregnant or nursing women, as some active compounds may cross the placenta or enter breast milk. Consult your healthcare provider before use if you are pregnant, planning pregnancy, or breastfeeding.
What does the clinical research actually show about chanca piedra's effectiveness?
While laboratory studies demonstrate that phyllanthin and hypophyllanthin can inhibit calcium oxalate crystal formation in vitro, human clinical trials remain limited and primarily consist of preliminary studies from Brazil. Existing clinical evidence suggests chanca piedra may reduce stone passage time and decrease urinary calcium, but larger, randomized controlled trials are needed to establish definitive efficacy. The evidence is considered moderate, supporting traditional use but not yet providing the robust proof standard for most conventional medical applications.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w chanca-piedra-phyllanthus-niruri curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
